Skip to main content

and
  1. Article

    Open Access

    CDK9 inhibition as an effective therapy for small cell lung cancer

    Treatment-naïve small cell lung cancer (SCLC) is typically susceptible to standard-of-care chemotherapy consisting of cisplatin and etoposide recently combined with PD-L1 inhibitors. Yet, in most cases, SCLC p...

    L. Valdez Capuccino, T. Kleitke, B. Szokol, L. Svajda, F. Martin in Cell Death & Disease (2024)